Oxycodone Hydrochloride Hydrate

盐酸羟考酮

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameOxycodone Hydrochloride Hydrate
Drug Alias NameOxycodone Hydrochloride羟考酮盐酸盐水合物盐酸羟考酮水合物Rexista Oxycodone XROROS-oxycodone +[30] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors agonists
TargetsOpioid receptors
Therapy Area/IndicationsDepressive DisorderAnxiety DisordersOpioid-Related Disorders +[10] 
Global Approved IndicationsChronic PainAcute PainPain
Approved Indications in ChinaChronic PainAcute Pain
Original Approved Country/TerritoryUnited States
Original Approved Date1998/10/26
Country/TerritoryUnited StatesRomaniaNew Zealand +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShionogi Pharma Co LtdUniversity Of California San FranciscoProtega Pharmaceuticals LLC +[4] 
Inactive CompaniesCassava Sciences IncPurdue Pharma LpPfizer Inc +[7] 
Active IndicationsDepressive DisorderAnxiety DisordersChronic Pain +[7] 
Inactive IndicationsOpioid-Related DisordersNarcotic-Related DisordersAnesthesia

Other Information

ATC CodeN02AA05
Related LinksWikipediaDrugBankKEGG